tiprankstipranks
Company Announcements

BlinkLab Partners with Chicago’s NSPT for US Autism Diagnostic Study

Story Highlights

Blinklab Limited ( (AU:BB1) ) has shared an announcement.

BlinkLab Limited has announced that North Shore Pediatric Therapy (NSPT), a leader in early autism intervention in Chicago, has joined its US clinical study. NSPT’s participation is expected to enhance the robustness and credibility of the study, which aims to validate BlinkLab’s Dx 1 test as an effective autism screening tool, leveraging NSPT’s expertise in the gold-standard ADOS-2 diagnostic tool and its access to a diverse pool of participants.

More about Blinklab Limited

BlinkLab Limited is an innovative digital healthcare company focused on developing AI-powered smartphone technology aimed at transforming the autism and ADHD diagnostic markets.

YTD Price Performance: 51.79%

Average Trading Volume: 292,196

Technical Sentiment Consensus Rating: Strong Sell

For detailed information about BB1 stock, go to TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1